Our findings suggest that the TCF7L2 rs77961654 polymorphism may be associated with CAD, characterized by distinct levels of HbA1C, total WBC count, lymphocyte count, adiponectin, and Sfrp5. Here, TCF7L2 is linked to coronary artery disorder.